您的位置: 首页 > 农业专利 > 详情页

UTILISATION D'ANTAGONISTES DE RÉCEPTEUR EP4 DANS LE TRAITEMENT DE MALADIES MÉDIÉES PAR IL-23
专利权人:
RAQUALIA PHARMA INC
发明人:
KANAZAWA, KIYOSHI,NONOMURA, KAZUHIKO,OKUMURA, TAKAKO,KOIZUMI, SHINICHI
申请号:
EP11744440
公开号:
EP2538978A4
申请日:
2011.02.22
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
This invention relates to a compound with EP4 antagonistic activity, or a pharmaceutically acceptable salt with EP4 receptor antagonistic activities, which is useful in the treatment of immune disease or allergy. This invention also relates to a compound of formula (I), (II), (III), (IV), (Va) or (Vb), or a pharmaceutically acceptable salt thereof with EP4 receptor antagonistic activities, which is useful in the treatment of immune disease or allergy. This invention also relates to a pharmaceutical composition for the treatment of immune disease or allergy which comprises a therapeutically effective amount of a compound of formula (I), (II), (III), (IV), (Va) or (Vb), or a pharmaceutically acceptable salt thereof. Further this invention relates to a method for the treatment of immune disease or allergy in an animal subject including a mammalian subject, which comprises administering to the animal subject including a mammalian subject a compound of the formula (I), (II), (III), (IV), (Va) or (Vb), or a pharmaceutically acceptable salt thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充